Skip to main navigation Skip to search Skip to main content

Future of ILD care and how nerandomilast will impact patients living with PF – panel discussion

Activity: Talk or presentation › Invited talk

Period23 Apr 2026
Held atBoehringer Ingelheim International GmbH, Germany, Rhineland-Palatinate
Degree of RecognitionNational